Page 139 - 2021_02-Haematologica-web

EASIX predicts SOS/VOD after alloSCT
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno- occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016;51(7):906-912.
5. Jones RJ, Lee KS, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44(6):778-783.
6. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and mul- tiorgan failure after bone marrow transplan- tation: a cohort study of 355 patients. Ann Intern Med. 1993;118(4):255-267.
7. Carreras E, Bertz H, Arcese W, et al. Incidence and outcome of hepatic veno- occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood. 1998;92 (10):3599-3604.
8. Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16(2):157-168.
9. Dalle J-H, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell trans- plantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016;22(3):400-409.
10. Carreras E, Diaz-Ricart M. The role of the endothelium in the short-term complica- tions of hematopoietic SCT. Bone Marrow Transplant. 2011;46(12):1495-1502.
11. Bearman S. The syndrome of hepatic veno- occlusive disease after marrow transplanta- tion. Blood. 1995;85(11):3005-3020.
12. Richardson PG, Smith AR, Triplett BM, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves day +100
survival following haematopoietic stem cell transplantation. Br J Haematol. 2017; 178(1):112-118.
13. Strouse C, Zhang Y, Zhang M-J, et al. Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant. Biol Blood Marrow Transplant. 2018;24(10):2072-2080.
14. Salat C, Holler E, Kolb H-J, et al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive dis- ease in patients with hyperbilirubinemia after bone marrow transplantation. Blood. 1997;89(6):2184-2188.
15. Tanikawa S, Mori S, Ohhashi K, et al. Predictive markers for hepatic veno-occlu- sive disease after hematopoietic stem cell transplantation in adults: a prospective sin- gle center study. Bone Marrow Transplant. 2000;26(8):881-886.
16. Cutler C, Kim HT, Ayanian S, et al. Prediction of veno-occlusive disease using biomarkers of endothelial injury. Biol Blood Marrow Transplant. 2010;16(8):1180-1185.
17. Akil A, Zhang Q, Mumaw CL, et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015; 21(10):1739-1745.
18. Piccin A, Sartori MT, Bisogno G, et al. New insights into sinusoidal obstruction syn- drome: microparticles and VOD. Intern Med J. 2017;47(10):1173-1183.
19. Luft T, Benner A, Jodele S, et al. EASIX in patients with acute graft-versus-host dis- ease: a retrospective cohort analysis. Lancet Haematol. 2017;4(9):e414-e423.
20. Zeisbrich M, Becker N, Benner A, et al. Transplant-associated thrombotic microan- giopathy is an endothelial complication associated with refractoriness of acute GvHD. Bone Marrow Transplant.
2017;52(10):1399-1405.
21. Gratwohl A, Stern M, Brand R, et al. Risk
score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009; 115(20):4715-4726.
22. Center for International Blood & Marrow Transplant Research. VOD Risk Calculator. 2018. https:// www.cibmtr.org/ Reference Center/Statistical/Tools/Pages/VOD.aspx (Last accessed August 24, 2018).
23. Ruutu T, Eriksson B, Remes K, et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood. 2002;100(6):1977- 1983.
24. Ruutu T, Juvonen E, Remberger M, et al. Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study. Biol Blood Marrow Transplant. 2014;20(1):135-138.
25. Cheuk DKL, Chiang AKS, Ha SY, Chan GCF. Interventions for prophylaxis of hepat- ic veno-occlusive disease in people undergo- ing haematopoietic stem cell transplanta- tion. Cochrane Database Syst Rev. 2015;(5):CD009311.
26. Lahera V, Goicoechea M, de Vinuesa SG, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: benefi- cial effects of statins. Curr Med Chem. 2007;14(2):243-248.
27. Blum A, Shamburek R. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis. 2009; 203(2):325-330.
28. Dietrich S, Okun JG, Schmidt K, et al. High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus- host disease in the absence of statin therapy. Haematologica. 2014;99(3):541-547.
haematologica | 2021; 106(2)
453